Pharmaceutical - Pharmaceutical, North America, Sigma-Tau

Filter

Regulatory briefs: Amitiza in Japan; Dificid in Canada; Eurartesim roll-out

06-07-2012

Sucampo Pharmaceuticals (Nasdaq: SCMP) and Abbott Labs (NYSE: ABT) have received approval from the Ministry…

Abbott LaboratoriesAmitizaAntibiotics and Infectious diseasesAsia-PacificDificidEurartesimGastro-intestinalsMarkets & MarketingNorth AmericaOptimer PharmaceuticalsPharmaceuticalRegulationSigma-TauSucampoTropical diseases

Back to top